Ayesa-Arriola R, Rodríguez-Sánchez JM, Morelli C, Pelayo-Terán JM, Pérez-Iglesias R, Mata I, Martínez-Garcia O, Pardo-Garcia G, Vazquez-Barquero JL, Crespo-Facorro B. Insight dimensions in first-episode psychosis patients: clinical, cognitive, pre-morbid and socio-demographic correlates. Early Interv. Psychiatry 2011; 5:140-149. F.I.: 1,169

Castro-Fornieles J, Baeza I, de la Serna E, Gonzalez-Pinto A, Parellada M, Graell M, Moreno D, Otero S, Arango C. Two-year diagnostic stability in early-onset first-episode psychosis. J. Child Psychol. Psychiatry 2011; 52:1089-1098. F.I.: 4,360

Crespo-Facorro B, Pérez-Iglesias R, Mata I, Caseiro O, Martínez-Garcia O, Pardo G, Ramirez-Bonilla M, Pelayo-Terán JM, Vázquez-Barquero JL. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. J. Psychiatr. Res. 2011; 45:763-769. F.I.: 3,827

Crespo-Facorro B, Pérez-Iglesias R, Mata I, Ramirez-Bonilla M, Martínez-Garcia O, Pardo-Garcia G, Caseiro O, Pelayo-Terán JM, Vázquez-Barquero JL. Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison. J. Psychopharmacol. 2011; 25:744-754. F.I.: 3,801

Crespo-Facorro B, Roiz-Santiáñez R, Pérez-Iglesias R, Mata I, Rodríguez-Sánchez JM, Tordesillas-Gutiérrez D, Ortíz-García de la Foz V, Tabarés-Seisdedos R, Sanchez E, Andreasen N, Magnotta V, Vázquez-Barquero JL. Sex-specific variation of MRI-based cortical morphometry in adult healthy volunteers: the effect on cognitive functioning. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2011; 35:616-623. F.I.: 2,877

Crespo-Facorro B, Roiz-Santiáñez R, Pérez-Iglesias R, Rodriguez-Sanchez JM, Mata I, Tordesillas-Gutierrez D, Sanchez E, Tabarés-Seisdedos R, Andreasen N, Magnotta V, Vázquez-Barquero JL. Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features. Psychol. Med. 2011; 41:1449-1460. F.I.: 5,200

Cuesta MJ, Pino O, Guilera G, Rojo JE, Gómez-Benito J, Purdon SE, Franco M, Martínez-Arán A, Segarra N, Tabarés-Seisdedos R, Vieta E, Bernardo M, Crespo-Facorro B, Mesa F, Rejas J. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP). Schizophr. Res. 2011; 130:137-142. F.I.: 4,374

Diaz FJ, Perez-Iglesias R, Mata I, Martínez-Garcia O, Vázquez-Barquero JL, de Leon J, Crespo-Facorro B. Using structural equations to test for a direct effect of some antipsychotics on triglyceride levels in drug-naïve first-episode psychosis patients. Schizophr. Res. 2011; 131:82-89. F.I.: 4,374

Fusar-Poli P, Crossley N, Woolley J, Carletti F, Perez-Iglesias R, Broome M, Johns L, Tabraham P, Bramon E, McGuire P. Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: longitudinal MRI-EEG study. Neuroimage 2011; 55:320-328. F.I.: 5,937

Fusar-Poli P, Crossley N, Woolley J, Carletti F, Perez-Iglesias R, Broome M, Johns L, Tabraham P, Bramon E, McGuire P. White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study. J. Psychiatry Neurosci. 2011; 36:239-248. F.I.: 4,893

González-Blanch C, Pérez-Iglesias R, Rodríguez-Sánchez JM, Pardo-García G, Martínez-García O, Vázquez-Barquero JL, Crespo-Facorro B. A digit symbol coding task as a screening instrument for cognitive impairment in first-episode psychosis. Arch. Clin. Neuropsychol. 2011; 26:48-58. F.I.: 2,304

González-Blanch C, Priede A, Rodríguez-Sánchez JM, Perez-Iglesias R, Vázquez-Barquero JL, Crespo-Facorro B. Identifying attentional deficits in people with first-episode psychosis with the Scale for the Assessment of Negative Symptoms attention subscale: is it possible?. Compr. Psychiat. 2011; 0-0. F.I.: 2,377

González-Pinto A, Ruiz de Azúa S, Ibáñez B, Otero-Cuesta S, Castro-Fornieles J, Graell-Berna M, Ugarte A, Parellada M, Moreno D, Soutullo C, Baeza I, Arango C. Can positive family factors be protective against the development of psychosis?. Psychiatry Res. 2011; 186:28-33. F.I.: 2,803

Micó JA, Rojas-Corrales MO, Gibert-Rahola J, Parellada M, Moreno D, Fraguas D, Graell M, Gil J, Irazusta J, Castro-Fornieles J, Soutullo C, Arango C, Otero S, Navarro A, Baeza I, Martínez-Cengotitabengoa M, González-Pinto A. Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry 2011; 11:26-26. F.I.: 2,891

Otero S, Moreno-Iniguez M, Payá B, Castro-Fornieles J, Gonzalez-Pinto A, Baeza I, Mayoral M, Graell M, Arango-López C. Twelve-month follow-up of family communication and psychopathology in children and adolescents with a first psychotic episode (CAFEPS study). Psychiatry Res. 2011; 185:72-77. F.I.: 2,803

Parellada M, Boada L, Fraguas D, Reig S, Castro-Fornieles J, Moreno D, Gonzalez-Pinto A, Otero S, Rapado-Castro M, Graell M, Baeza I, Arango C. Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study. Schizophr. Bull. 2011; 37:38-51. F.I.: 8,273

Pelayo-Terán JM, Pérez-Iglesias R, Vázquez-Bourgon J, Mata I, Carrasco-Marín E, Vázquez-Barquero JL, Crespo-Facorro B. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis. Psychiatry Res. 2011; 185:286-289. F.I.: 2,803

Reig S, Parellada M, Castro-Fornieles J, Janssen J, Moreno D, Baeza I, Bargalló N, González-Pinto A, Graell M, Ortuño F, Otero S, Arango C, Desco M. Multicenter study of brain volume abnormalities in children and adolescent-onset psychosis. Schizophr. Bull. 2011; 37:1270-1280. F.I.: 8,273

Roiz-Santiáñez R, Pérez-Iglesias R, Ortiz-García de la Foz V, Tordesillas-Gutiérrez D, Mata I, Marco de Lucas E, Pazos A, Tabarés-Seisdedos R, Vázquez-Barquero JL, Crespo-Facorro B. Straight gyrus morphology in first episode schizophrenia spectrum patients. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2011; 35:84-90. F.I.: 2,877

Tabarés-Seisdedos R, Dumont N, Baudot A, Valderas JM, Climent J, Valencia A, Crespo-Facorro B, Vieta E, Gómez-Beneyto M, Martínez S, Rubenstein JL. No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol. 2011; 12:604-608. F.I.: 17,764